PubMed:21740819 / 171-589 JSONTXT

{"project":"PubMed_Structured_Abstracts","denotations":[{"id":"T1","span":{"begin":0,"end":418},"obj":"BACKGROUND"}],"text":"Ovarian cancers are often at an advanced stage at diagnosis because early detection is difficult. The poor prognosis of ovarian cancers highlights the crucial need to develop better therapeutic agents and strategies. The objective of this study was to investigate the inhibitory effects of a new modified antisense oligonucleotides targeting vascular endothelial growth factor A (VEGF-A) in SKOV3 ovarian cancer cells."}

{"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":0,"end":15},"obj":"HP_0100615"},{"id":"T2","span":{"begin":8,"end":15},"obj":"HP_0002664"},{"id":"T3","span":{"begin":120,"end":135},"obj":"HP_0100615"},{"id":"T4","span":{"begin":128,"end":135},"obj":"HP_0002664"},{"id":"T5","span":{"begin":397,"end":411},"obj":"HP_0100615"},{"id":"T6","span":{"begin":405,"end":411},"obj":"HP_0002664"}],"text":"Ovarian cancers are often at an advanced stage at diagnosis because early detection is difficult. The poor prognosis of ovarian cancers highlights the crucial need to develop better therapeutic agents and strategies. The objective of this study was to investigate the inhibitory effects of a new modified antisense oligonucleotides targeting vascular endothelial growth factor A (VEGF-A) in SKOV3 ovarian cancer cells."}

{"project":"Allie","denotations":[{"id":"SS1_21740819_4_0","span":{"begin":342,"end":378},"obj":"expanded"},{"id":"SS2_21740819_4_0","span":{"begin":380,"end":386},"obj":"abbr"}],"relations":[{"id":"AE1_21740819_4_0","pred":"abbreviatedTo","subj":"SS1_21740819_4_0","obj":"SS2_21740819_4_0"}],"text":"Ovarian cancers are often at an advanced stage at diagnosis because early detection is difficult. The poor prognosis of ovarian cancers highlights the crucial need to develop better therapeutic agents and strategies. The objective of this study was to investigate the inhibitory effects of a new modified antisense oligonucleotides targeting vascular endothelial growth factor A (VEGF-A) in SKOV3 ovarian cancer cells."}